ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Liver Preservation with Machine Perfusion and a New Human-Derived Hemoglobin-Based Oxygen Carrier Solution (HDHBOC)

W. R. Light,1 A. Malavalli,1 K. Vandegriff,1 P. Fontes.2

1VirTech Bio, Inc, Natick, MA
2University of Pittsburgh, Pittsburgh, PA.

Meeting: 2018 American Transplant Congress

Abstract number: D299

Keywords: Bioengineering, Donors, marginal

Session Information

Session Name: Poster Session D: Late Breaking

Session Type: Poster Session

Date: Tuesday, June 5, 2018

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall 4EF

Introduction: Machine perfusion (MP) is becoming the new standard for liver preservation following the successful implementation of devices for kidney and lung preservation ex-vivo. Liver preservation is being performed within a wide temperature range from hypothermia (4[deg]C) to normothermia 37[deg]C. We present here our initial experience with MP under subnormothermic (21[deg]C) conditions using a new HDHBOC specially developed for ex-vivo applications. The new HBOC hasa higher molecular weight and viscosity to limit extravasation into tissues (MW [sim] 1,000 kD, 15 cPs) while engineered for cost-effective production through scalable filtration technology.

Methods: Swine liver allografts (n=6) were preserved for 12 hours with the Liver Assist® device. Tissue and perfusate samples were obtained every 3 hours. The livers were not transplanted and underwent full histological analysis at the completion of the MP protocol. The control group (n=3) was perfused with a bovine-derived HBOC (BDHBOC) and the study group (n=3) was perfused with the HDHBOC. Both groups had a low hemoglobin (Hb) concentration (3g/dL) in the perfusate. Tissue oxygenation (ptO2) was assessed with oximetry probes inserted in the hepatic parenchyma.

Results: Liver allografts cleared lactate effectively while sustaining a stable pH. The pO2 were >500 mmHg and ptO2>200mmHg on both groups. The pCO2 was lower (<20 mmHg) in the study group. Mitochondrial function (RCR, Maximal Respiratory Rate) was properly sustained on both groups, and levels of ROS (H2O2) remained low (<6000 pmol/min/mg) as well as nitrate and nitrite concentrations. The study group remained anatomically intact (histological and EM analysis) throughout the entire duration of the experiments while the control group showed progressive sinusoidal endothelial cell (SEC) damage, early cell detachment and progressive amount of cell debris accumulation in the sinusoids after 9 hours. The 12-hour biopsies showed a significant difference between the 2 groups regarding SEC integrity.

Conclusions: MP with HBOCs at 21[deg]C provides effective oxygenation for liver allografts over a 12-hour period. Despite low Hb concentrations, both HBOCs provided effective oxygenation and CO2 removal over 12 hours. The prolonged use of BDHBOC has a negative impact in SEC and sinusoidal integrity that might affect the liver allograft function after reperfusion. The new HDHBOC appears to correct this complication.

CITATION INFORMATION: Light W. R., Malavalli A., Vandegriff K., Fontes P. Liver Preservation with Machine Perfusion and a New Human-Derived Hemoglobin-Based Oxygen Carrier Solution (HDHBOC) Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Light WR, Malavalli A, Vandegriff K, Fontes P. Liver Preservation with Machine Perfusion and a New Human-Derived Hemoglobin-Based Oxygen Carrier Solution (HDHBOC) [abstract]. https://atcmeetingabstracts.com/abstract/liver-preservation-with-machine-perfusion-and-a-new-human-derived-hemoglobin-based-oxygen-carrier-solution-hdhboc/. Accessed May 9, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences